...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

"Do you think we will be able to compare apples and oranges between the Montreal Cognition trial results with what Biogen's phase 2 trial used for it's alzheimer's drug,..?"

Some comparisons can be made, but with the big caveats of there being huge differences in the trial design, patient populations, and endpoints.

BDAZ

Share
New Message
Please login to post a reply